Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?-Reference-Cited by-同舟云学术

Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?

Published:2017-08-07 Issue:5 Volume:30 Page:395-397
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Semin Dial

Author:

Jadoul Michel¹,Martin Paul²

Affiliation:

1. Division of Nephrology; Cliniques universitaires Saint-Luc; Université catholique de Louvain; Brussels Belgium

2. Division of Hepatology; University of Miami; Florida USA

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12640/fullpdf

Reference27 articles.

1. Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial;Bruchfeld;Lancet Gastroenterol Hepatol,2017

2. Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease;Pockros;Gastroenterology,2016

3. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: a multicentre experience;Muñoz-Gómez;J Viral Hepat,2017

4. Gane E Lawitz E Pugatch D Expedition-4: efficacy and safety of glecaprevir/pibrentasvir (abt-493/abt-530) in patients with renal impairment and chronic hepatitis c virus genotype 1-6 infection Boston, Massachusetts

5. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!;Morelle;Transpl Int,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poor management of hepatitis C infection will cause serious issues for patients with advanced chronic kidney disease;Journal of Evidence-Based Medicine;2021-05

2. Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study;Annals of Gastroenterology;2021

3. Hepatitis C virus infection in patients with end-stage renal disease;Hemodialysis International;2018-07

4. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes;American Journal of Transplantation;2018-05-29

5. Dialysis facility screening and testing practices in the era of improved hepatitis C treatment;Journal of Viral Hepatitis;2018-05-08